You just read:

Positive Interim Results From Second Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Presented At American Thoracic Society International Conference

News provided by

Mast Therapeutics, Inc.

May 16, 2016, 08:00 ET